• 沒有找到結果。

SYNDROMES, DISORDERS AND MATERNAL RISK FACTORS ASSOCIATED WITH NEURAL TUBE DEFECTS (I)

N/A
N/A
Protected

Academic year: 2022

Share "SYNDROMES, DISORDERS AND MATERNAL RISK FACTORS ASSOCIATED WITH NEURAL TUBE DEFECTS (I)"

Copied!
3
0
0

加載中.... (立即查看全文)

全文

(1)

Author(s): Chen, CP (Chen, Chih-Ping)

Title: SYNDROMES, DISORDERS AND MATERNAL RISK FACTORS ASSOCIATED WITH NEURAL TUBE DEFECTS (I)

Source: TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 47 (1): 1-9 MAR 2008 Language: English

Document Type: Review

Author Keywords: congenital malformations; disorder; maternal risk factors; neural tube defects; syndromes

KeyWords Plus: FETAL VALPROATE SYNDROME; SPINA-BIFIDA-APERTA; RIB- POLYDACTYLY SYNDROME; ACROCALLOSAL SYNDROME; WAARDENBURG- SYNDROME; PRENATAL-DIAGNOSIS; CONGENITAL-ANOMALIES; DIABETIC PREGNANCY; KOUSSEFF-SYNDROME; BIRTH-DEFECTS

Abstract: Fetuses with neural tube defects (NTDs) may be associated with syndromes, disorders, and maternal risk factors. This article provides a comprehensive review of syndromes, disorders, and maternal risk factors associated with NTDs, such as acrocallosal syndrome, autosomal dominant brachydactyly-clinodactyly syndrome, Manouvrier syndrome, short rib-polydactyly syndrome, Disorganization (Ds)-like human malformations, isolated hemihyperplasia, X-linked NTDs, meroanencephaly, schisis association, diprosopus, fetal valproate syndrome, DiGeorge syndrome/velocardicifacial syndrome, Waardenburg syndrome, folic acid antagonists, diabetes mellitus, and obesity. NTDs associated with syndromes, disorders, and maternal risk factors are a rare but important cause of NTDs. The recurrence risk and the preventive effect of maternal folic acid intake in NTDs associated with syndromes, disorders, and maternal risk factors may be different from those of non-syndromic multifactorial NTDs. Perinatal identification of NTDs should alert one to the syndromes, disorders, and maternal risk factors associated with NTDs, and prompt a thorough etiologic investigation and genetic counseling. [Taiwan J Obstet Gynecol 2008;47(1):1-9]

Addresses: [Chen, Chih-Ping] MackayMem Hosp, Dept Obstet & Gynecol, Taipei, Taiwan;

[Chen, Chih-Ping] MackayMem Hosp, Dept Med Res, Taipei, Taiwan; [Chen, Chih-Ping] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Chen, Chih-Ping] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan; [Chen, Chih-Ping] Natl Yang Ming Univ, Inst Clin &

Community Hlth Nursing, Taipei 112, Taiwan

Reprint Address: Chen, CP, MackayMem Hosp, Dept Obstet & Gynecol, 92,Sect 2,Chung Shan N Rd, Taipei, Taiwan.

E-mail Address: cpc_mmh@yahoo.com

Cited References: ALSDORF R, 2005, EXPERT OPIN DRUG SAF, V4, P345.

ANDERSON JL, 2005, EPIDEMIOLOGY, V16, P87, DOI 10.1097/01.ede.0000147122.97061.bb.

(2)

ARDINGER HH, 1988, AM J MED GENET, V29, P171.

AYME S, 1995, AM J MED GENET, V59, P263.

BARAITSER M, 1984, AM J MED GENET, V17, P383.

BARR M, 1982, TERATOLOGY, V25, P153.

BULBUL Y, 2004, FETAL DIAGN THER, V19, P246, DOI 10.1159/000076706.

CATALTEPE S, 1992, EUR J PEDIATR, V151, P288.

CHANG TI, 1999, SEMIN REPROD ENDOCR, V17, P153.

CHANG TI, 2003, DIABETOLOGIA, V46, P538, DOI 10.1007/s00125-003-1063-2.

CHANGARIS DG, 1976, ARCH PATHOL LAB MED, V100, P392.

CHATKUPT S, 1993, J MED GENET, V30, P83.

CHEN CP, 2005, GENET COUNSEL, V16, P313.

CHERVENAK FA, 1985, J REPROD MED, V30, P74.

CHRISTENSEN B, 2000, AM J MED GENET, V91, P231.

CLAYTONSMITH J, 1995, J MED GENET, V32, P724.

CORONARIVERA JR, 2003, CLIN DYSMORPHOL, V12, P51, DOI 10.1097/01.mcd.0000047372.23622.d4.

CZEIZEL A, 1981, AM J MED GENET, V10, P25.

DILIBERTI JH, 1984, AM J MED GENET, V19, P473.

EKINCI G, 2005, TURKISH J PEDIATR, V47, P195.

ELCIOGLU NH, 2002, AM J MED GENET, V111, P392, DOI 10.1002/ajmg.10562.

ELSON E, 2002, J MED GENET, V39, P804.

FINE EL, 1999, DIABETES, V48, P2454.

FONTANAROSA M, 1992, J CLIN ULTRASOUND, V20, P69.

FORRESTER S, 2002, AM J MED GENET, V112, P338, DOI 10.1002/ajmg.10625.

FRYNS JP, 1996, GENET COUNSEL, V7, P159.

GELMANKOHAN Z, 1991, EUR J PEDIATR, V150, P797.

GORDON DF, 1996, DNA CELL BIOL, V15, P531.

GUIBAUD S, 1993, PRENATAL DIAG, V13, P772.

HENDRICKS KA, 2001, EPIDEMIOLOGY, V12, P630.

HERNANDEZDIAZ S, 2001, AM J EPIDEMIOL, V153, P961.

HO NC, 2000, AM J MED GENET, V90, P310.

HOL FA, 1994, HUM GENET, V93, P452.

HOL FA, 1995, J MED GENET, V32, P52.

HOL FA, 2000, GENOMICS, V69, P174.

ISADA NB, 1993, FETAL DIAGN THER, V8, P423.

JENSSON O, 1988, J MED GENET, V25, P227.

JONES KL, 2006, SMITHS RECOGNIZABLE, P252.

(3)

KALLEN AJB, 1994, REPROD TOXICOL, V8, P203.

KEDAR I, 1996, AM J MED GENET, V62, P415.

KOUSSEFF BG, 1984, PEDIATRICS, V74, P395.

KUJAT A, 2007, FETAL DIAGN THER, V22, P155, DOI 10.1159/000097117.

LACHMAN RS, 1996, RADIOLOGY SYNDROMES, P745.

LINDHOUT D, 1986, LANCET, V1, P1392.

LOEKEN MR, 2004, J MATERN-FETAL NEO M, V15, P6.

LOEKEN MR, 2005, AM J MED GENET C C, V135, P77, DOI 10.1002/ajmg.c.30056.

LURIE IW, 1994, CLIN DYSMORPHOL, V3, P31.

MACLEAN K, 2004, AM J MED GENET A A, V124, P307, DOI 10.1002/ajmg.a.20418.

MANOUVRIER S, 2000, AM J MED GENET, V90, P351.

MARTINEZFRIAS ML, 1993, AM J MED GENET, V47, P782.

MARTINEZFRIAS ML, 1993, J MED GENET, V30, P937.

MARTINEZFRIAS ML, 1997, AM J MED GENET, V70, P16.

MATALON S, 2002, REPROD TOXICOL, V16, P9.

MCGAHAN JP, 2003, DIAGNOSTIC IMAGING F, P291.

MILLS JL, 1979, DIABETES, V28, P292.

MOERMAN P, 1983, CLIN GENET, V24, P252.

NEWTON R, 1994, CLIN GENET, V45, P241.

NICKEL RE, 1994, AM J MED GENET, V52, P445.

NUDLEMAN K, 1984, BRAIN, V107, P533.

NYE JS, 1998, AM J MED GENET, V75, P401.

OMTZIGT JGC, 1992, NEUROLOGY S5, V42, P119.

OMTZIGT JGC, 1992, PRENATAL DIAG, V12, P893.

PANI L, 2002, DIABETES, V51, P2871.

PANI L, 2002, GENE DEV, V16, P676.

PAVONE L, 1987, AM J MED GENET, V28, P85.

PFEIFFER RA, 1992, ANN GENET-PARIS, V35, P41.

PHELAN SA, 1997, DIABETES, V46, P1189.

PLAJA A, 1994, PRENATAL DIAG, V14, P410.

RAY JG, 2004, QJM-INT J MED, V97, P651, DOI 10.1093/qjmed/hch107.

RICCARDI VM, 1977, TERATOLOGY, V16, P137.

ROBIN NH, 1997, AM J MED GENET, V73, P425.

ROSA FW, 1991, NEW ENGL J MED, V324, P674.

RYDNERT J, 1985, ACTA OBSTET GYNECOL, V64, P687.

SARAFOGLOU K, 1999, CLIN GENET, V56, P145.

SCHINZEL A, 1979, HELV PAEDIATR ACTA, V34, P141.

(4)

SCIALLI AR, 2006, BIRTH DEFECTS RES A, V76, P73, DOI 10.1002/bdra.20236.

SELLER MJ, 2002, CLIN DYSMORPHOL, V11, P113.

SHARONY R, 1993, BIRTH DEFECTS, V29, P201.

SHAW GM, 1996, JAMA-J AM MED ASSOC, V275, P1093.

SHAW GM, 2000, PAEDIATR PERINAT EP, V14, P234.

SHAW GM, 2003, AM J CLIN NUTR, V78, P972.

SHIM SH, 2004, CLIN GENET, V66, P46, DOI 10.1111/j.1399-0004.2004.00276.x.

STAGIANNIS KD, 1995, PRENATAL DIAG, V15, P70.

STRAUSS S, 1987, J ULTRAS MED, V6, P93.

TENDONKELAAR HJ, 2002, CLIN DYSMORPHOL, V11, P9.

TORIELLO HV, 1980, AM J MED GENET, V6, P119.

TORIELLO HV, 1984, AM J MED GENET, V19, P411.

WALLER DK, 1994, AM J OBSTET GYNECOL, V170, P541.

WATKINS ML, 1996, EPIDEMIOLOGY, V7, P507.

WATKINS ML, 2003, PEDIATRICS S, V111, P1152.

WERLER MM, 1996, JAMA-J AM MED ASSOC, V275, P1089.

WINTER RM, 1987, J MED GENET, V24, P692.

ZAITOUN AAM, 1999, PATHOL RES PRACT, V195, P45.

ZHAO GQ, 1993, P NATL ACAD SCI USA, V90, P8633.

ZHAO Q, 1996, NAT GENET, V13, P275.

ZLOTOGORA J, 1995, AM J HUM GENET, V56, P1173.

Cited Reference Count: 96 Times Cited: 4

Publisher: ELSEVIER SINGAPORE PTE LTD

Publisher Address: 3 KILLINEY ROAD 08-01, WINSLAND HOUSE 1, SINGAPORE, 239519, SINGAPORE

ISSN: 1028-4559

29-char Source Abbrev.: TAIWAN J OBSTET GYNECOL ISO Source Abbrev.: Taiwan. J. Obstet. Gynecol.

Source Item Page Count: 9

Subject Category: Obstetrics & Gynecology ISI Document Delivery No.: 369DE

參考文獻

相關文件

Crystal-storing histiocytosis (CSH), a rare condition in which crystalline material accumulates in the cytoplasm of histiocytes, is typically associated with disorders that

(1) Crystal-storing histiocytosis (CSH), a rare condition in which crystalline material accumulates in the cytoplasm of histiocytes, is typically associated with disorders that

The Gorlin-Goltz syndrome:an autosomal dominant inherited syndrome →multiple defects involving the skin, nervous system, eyes,. endocrine system, and bones =Basal

The aim of this article is to review the management of oral leukoplakia. The topics of interest are clinical diagnosis, methods of management and their outcome, factors associated

SUMMARY The purpose of this systematic review was to describe the prevalence of whiplash trauma in patients with temporomandibular disorders (TMDs) and to describe clinical signs

The great majority of HPV relate SCC of the OP is nonkeratinizing as described above. However, more re- cently increasing numbers of variants of squamous cell carcinoma,

Accurate identification of the microscopic risk factors of oral and oropharyngeal (OP) squamous cell carcinomas (SCC) and their morphologic variants is of at most importance, as

Among the diseases that cause by mouth papillomatous lesions, the main disease that should be included in the differential diagnosis of CS is Heck’s Disease, characterized by